This company listing is no longer active
Sirnaomics Crecimiento futuro
Future controles de criterios 2/6
Sirnaomics is forecast to grow revenue at 63.5% per annum.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Biotechs | 41.8% |
Tasa de crecimiento de los ingresos | 63.5% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | 03 Jun 2024 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 161 | N/A | -138 | N/A | 1 |
12/31/2025 | 70 | N/A | -159 | N/A | 1 |
12/31/2024 | 2 | -124 | -120 | -126 | 1 |
6/30/2024 | 1 | -82 | -49 | -47 | N/A |
3/31/2024 | 1 | -80 | -61 | -59 | N/A |
12/31/2023 | 0 | -79 | -72 | -70 | N/A |
9/30/2023 | 0 | -82 | -82 | -76 | N/A |
6/30/2023 | 0 | -84 | -93 | -82 | N/A |
3/31/2023 | 0 | -86 | -100 | -85 | N/A |
12/31/2022 | 1 | -88 | -108 | -89 | N/A |
9/30/2022 | 1 | -230 | -103 | -87 | N/A |
6/30/2022 | 1 | -223 | -96 | -83 | N/A |
3/31/2022 | 0 | -218 | -80 | -70 | N/A |
12/31/2021 | 0 | -213 | -63 | -57 | N/A |
9/30/2021 | 0 | -60 | -49 | -44 | N/A |
12/31/2020 | N/A | -44 | -21 | -19 | N/A |
12/31/2019 | 0 | -16 | -16 | -14 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if 2257's forecast earnings growth is above the savings rate (2.3%).
Beneficios vs. Mercado: Insufficient data to determine if 2257's earnings are forecast to grow faster than the Hong Kong market
Beneficios de alto crecimiento: Insufficient data to determine if 2257's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: 2257's revenue (63.5% per year) is forecast to grow faster than the Hong Kong market (7.3% per year).
Ingresos de alto crecimiento: 2257's revenue (63.5% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if 2257's Return on Equity is forecast to be high in 3 years time